药艾灸与清艾灸对脾虚痰湿型高脂血症患者脂质代谢的影响
[Abstract]:Purpose 1. To observe the effect of mild moxibustion with different moxibustion materials on TC,TG,HDL-C, LDL-C,apoA,apoB and Lp (a) in hyperlipidemia patients with spleen deficiency and phlegm dampness. To observe the difference of curative effect between herbal moxibustion and clear moxibustion on hyperlipidemia with spleen deficiency and phlegm dampness. Methods 90 cases of hyperlipidemia with spleen deficiency and phlegm dampness type were randomly divided into three groups: Qingai group and control group (Xuezhikang group). 30 cases in each group were treated with the same acupoint prescription: Zhongwan, Liangmen (double) and Qihai, respectively. On Juxu (Shuang), Feng long (Shuang), Gongsun (Shuang). The medicine and the clear moxa are made by the moxa machine. The compound Chinese medicine powder is mixed evenly in the Ailong. The pure Artemisia lanceolata is used to make 18 mm diameter and length 20cm specification of the moxa. The two groups were treated with moxibustion by moxibustion frame for 40 mins and moxibustion every other day three times a week for a period of 2 months. In the control group, 0.6 g of Xuezhikang capsule was taken orally twice a day, and the course of treatment was two months after morning and evening meal. Blood samples were taken before and after treatment to examine the biochemical level of blood lipids. Results: (1) before treatment, there was no significant difference in TC,TG,HDL-C,LDL-C,apoA,apoB, age, sex and course of disease among the three groups (P0.05). At the end of the course of treatment, 28 patients in the control group were treated with abscission, 2 with abscission, 21 with remarkable effect, 6 with efficacy and 1 with no effect. The total effective rate was 96.42 in the control group, 29 patients in the control group, 1 case in the control group, 19 cases in the marked effect, 8 cases in the effective rate and 2 cases in the ineffective group. The total effective rate was 93.100.The total effective rate was 88.46 in the Qingai group (n = 26), there were 4 cases of shedding, 15 cases of remarkable effect, 8 cases of effective and 3 cases of ineffectiveness. There was no significant difference (P0.05). (2) in serum TC,TG,LDL-C,apoB content between the three groups. Compared with before treatment, the three groups were lower after treatment, the differences were statistically significant (P0.05); after treatment, the treatment group, Qingai group and control group were compared. Compared with Qingai group, there was no significant difference (P0.05). (3) in serum HDL-C,apoA content, compared with before treatment, the three groups were increased after treatment, the difference was statistically significant (P0.05); after treatment, the treatment group, Qing Ai group and control group were compared. There was no significant difference (P0.05), there was significant difference between the two groups (P0.05). (P0.05) the content of apoA. (4) in the apoA. (4) of the apoAX group was significantly higher than that of the control group (P0.05). The serum Lp (a) content of the three groups was significantly different before treatment, and there was significant difference between the three groups. There is no comparability. After treatment, the control group, the drug group, serum Lp (a) levels were decreased, compared with before treatment, the difference was statistically significant (P0.05); Qing Ai group and before treatment, there was no significant difference (P0.05). Conclusion: (1) the levels of serum TC,TG,LDL-C and apoB in patients with hyperlipidemia due to spleen deficiency and phlegm dampness can be decreased, and the levels of HDL-C and apoA are increased, which can regulate the metabolism of blood lipids. (2) the effect of drug moxibustion on raising serum HDL-C,apoA in patients with hyperlipidemia of spleen deficiency and phlegm dampness was better than that of clear moxibustion, and it could reduce serum Lp (a) content of patients with hyperlipidemia.
【学位授予单位】:福建中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R246.1
【相似文献】
相关期刊论文 前10条
1 ;高脂血症[J];广西中医药;2000年04期
2 李学英;中小学教师高脂血症情况调查[J];中国校医;2000年03期
3 ;高脂血症[J];中国健康教育;2000年06期
4 宋玉茹,李淑云,齐建强;自拟清脂汤治疗高脂血症的临床研究[J];中医药学报;2000年02期
5 刘巨华,苏海禄;不同年龄女性高脂血症发病特点分析——附2318例报告[J];岭南心血管病杂志;2001年03期
6 傅善来;;哪种人容易患高脂血症?[J];乡镇企业科技;2002年03期
7 王洪伦,索有瑞,李天才;红珍珠血脂康胶囊治疗高脂血症的疗效观察[J];西北药学杂志;2003年05期
8 郭新瑛,郭文建;氟伐他丁治疗高脂血症35例[J];实用医药杂志;2003年12期
9 赵燕,王海安;高脂血症的危害及防治[J];社区医学杂志;2003年03期
10 张燕;;清脂饮治疗高脂血症50例[J];中医杂志;2003年04期
相关会议论文 前10条
1 蒋晓婷;周永列;刘建栋;;高脂血症与急性坏死性胰腺炎关系研究[A];2004年浙江省检验医学学术会议论文汇编[C];2004年
2 易忠群;程新宪;陈燕妮;张婧;孙敏;何颖;;低镁、低胆红素水平在高脂血症中的临床意义探讨[A];第十届全军检验医学学术会议论文汇编[C];2005年
3 杨为民;饶可;杜广辉;;高脂血症与男性勃起功能障碍[A];湖北省性学会第二届第二次学术年会论文集[C];2005年
4 汤军;朱雅芳;孙洁;宋嘉;;3140名医务人员高脂血症分析[A];浙江省医学会健康管理学分会成立大会暨首届学术年会论文集[C];2008年
5 茹利敏;;高脂血症患者的健康教育[A];河南省护理健康教育学术会议暨神经系统疾病护理健康教育研修班论文集[C];2013年
6 田芳;刘景芳;陆冬梅;;高脂血症并发多器官损害的高龄患者低热能饮食治疗1例[A];中国营养学会第12届全国临床营养学术会议资料汇编[C];2009年
7 常亚霖;张琳;顾崇梅;杨铖;;中西医结合治疗高脂血症160例临床观察[A];甘肃省中医药学会2010年会员代表大会暨学术年会论文汇编[C];2010年
8 庞晓军;;治疗高脂血症药物的合理应用[A];全国第三届心脑血管疾病学术会议论文集[C];2003年
9 依巴代提·阿塔吾拉;阿不力孜·阿不都拉;;增强肝功能药物治疗39例高脂血症[A];第五届全国民族医药学术交流大会论文集[C];2006年
10 赵厚熙;;中药对高脂血症的治疗和研究近况[A];中华中医药学会心病分会第十一届学术年会论文精选[C];2009年
相关重要报纸文章 前10条
1 廖艺;专家呼吁:重视和防治高脂血症[N];江苏科技报;2000年
2 王玉泽;耳聋多因高脂血症[N];卫生与生活报;2007年
3 河北医大一院 主任医师 杨秀芬 医师 苏冠丽;高脂血症也“伤心”[N];家庭医生报;2009年
4 武汉大学中山医院主任医师 李定国;撩开高脂血症的面纱[N];医药经济报;2010年
5 ;调整膳食结构 远离高脂血症[N];保健时报;2005年
6 安徽省皖南医学院 黄文斌;儿童也患高脂血症[N];大众卫生报;2003年
7 ;高脂血症:沉默的杀手[N];人民政协报;2004年
8 白静 罗云;高脂血症有什么危害[N];医药养生保健报;2004年
9 马月娥;儿童也有高脂血症[N];中国中医药报;2006年
10 ;高脂血症的化验分型[N];农村医药报(汉);2008年
相关博士学位论文 前10条
1 张莎莎;细胞色素P450表氧化酶2J2基因过表达通过增加脂肪酸氧化改善小鼠高脂血症[D];华中科技大学;2015年
2 尚菊菊;黄丽娟教授学术思想临床经验总结及治疗高脂血症的临床研究[D];北京中医药大学;2016年
3 聂文强;健脾调脂方治疗高脂血症的基础研究与临床研究[D];广州中医药大学;2015年
4 江丽霞;针刺对高脂血症模型大鼠干预作用的研究[D];广州中医药大学;2010年
5 金英姬;脂蛋白(a)及高脂血症长期作用对冠状动脉粥样硬化发生的影响:利用转基因家族性高脂血症家兔模型的病理学分析[D];吉林大学;2006年
6 孟伟;清脂六通丸治疗高脂血症气滞血瘀痰浊内阻证多中心临床研究[D];北京中医药大学;2006年
7 韩荣;高脂血症中医“血脉微型ve瘕”论及其软坚散结法方药的研究[D];新疆医科大学;2011年
8 吴峻;高脂血症与内皮功能障碍相关性研究及贝特类干预治疗机制探讨[D];中南大学;2003年
9 汤永辉;高脂血症与急性胰腺炎关系研究[D];南京医科大学;2009年
10 华丛笑;高脂血症患者服用调脂药物的血浆蛋白质组学研究[D];中国协和医科大学;2008年
相关硕士学位论文 前10条
1 叶秀卿;泽泻调脂颗粒方治疗脾虚痰瘀型高脂血症的临床疗效观察[D];福建中医药大学;2015年
2 岳树豪;高血压病合并高脂血症的中医证候特点研究[D];北京中医药大学;2016年
3 王骁腾;新疆高脂血症中医证候及相关因素的临床研究[D];新疆医科大学;2016年
4 张燕春;甘肃省临夏州高脂血症流行病学调查[D];兰州大学;2016年
5 卞亚琴;佛山南海某村高脂血症人群的体成分和中医体质特征研究[D];广州中医药大学;2016年
6 李慧丽;肥胖、糖尿病、高脂血症与急性胰腺炎关系研究[D];山东大学;2016年
7 林彬彬;药艾灸与清艾灸对脾虚痰湿型高脂血症患者脂质代谢的影响[D];福建中医药大学;2016年
8 张治三;中医辨证施治、辛伐他汀干预高脂血症的随机对照临床研究[D];福建中医药大学;2016年
9 刘冲;高脂血症的证型特点研究[D];福建中医药大学;2016年
10 史丽伟;运脾通心方治疗高脂血症的临床研究[D];中国中医科学院;2016年
,本文编号:2209029
本文链接:https://www.wllwen.com/zhongyixuelunwen/2209029.html